Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christina Bello
Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Bortezomib and Dexamethasone Consolidation Following Risk-Adapted Melphalan and Stem Cell Transplantation for Patients With Newly Diagnosed Light-Chain Amyloidosis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Maintained Hematologic and Organ Responses Following Risk Adapted Stem Cell Transplant (SCT) in Systemic Light-Chain Amyloidosis (AL) Using Bortezomib and Dexamethasone as Consolidation Therapy
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Impact of Prior Melphalan Exposure on Stem Cell Collection in Light Chain Amyloidosis
Bone Marrow Transplantation
Transplantation
Hematology
Autologous Stem Cell Transplant in the Era of Bortezomib-Based Induction for AL Amyloidosis – A Single Institution 11 Year Experience
Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Stem Cell Transplantation Compared With Melphalan Plus Dexamethasone in the Treatment of Immunoglobulin Light-Chain Amyloidosis
Cancer
Cancer Research
Oncology
Busulfan–melphalan in High-Risk Neuroblastoma: The 30-Year Experience of a Single Institution
Bone Marrow Transplantation
Transplantation
Hematology
Systemic Light Chain Amyloidosis Mimicking Rheumatic Disorders
Case Reports in Medicine
Medicine
Timing of Stem Cell Transplantation and Outcomes in Light Chain Amyloidosis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
